This study examined the transcriptomic (gene expression) changes associated with Mind-Body Transformations (MBT) therapy in breast cancer patients, with a focus on identifying affected biological signaling pathways.
MBT therapy was associated with downregulation of the interferon signaling pathway in breast cancer patients, as detected through transcriptomic analysis.
Only the abstract/metadata is available; sample size, comparator groups, follow-up duration, and clinical outcomes are not reported here. Causal inference is limited without a randomized design confirmed in the text.
MBT therapy may modulate immune-related gene expression in breast cancer; however, clinical significance and patient selection criteria require further study before practice adoption.
Explore related topics
